In 2021, we continued with our social commitment in the face of the pandemic. Since 2020, we have invested R$ 78 million in initiatives focused on donating tests, supporting hospitals, assigning professionals and infrastructure, and sequencing variants. The main highlights for the period include:
The launch of Genov, a scientific genomic surveillance project designed to track COVID-19 variants. 
The donation of human resources and infrastructure for processing 2 million RT-PCR tests for COVID-19 detection to Brazil's national health system (Sistema Único de Saúde - SUS); 
The donation of R$2 million to build Hospital de Samambaia in the Federal District and R$1.5 million to equip Hospital da Lagoa in Rio de Janeiro, both in partnership with Rede D’Or. 
Driving transformation in the healthcare sector, with an integrated and preventive view of care, mainly involves ensuring an intuitive experience for physicians, patients, and users. It is in this context that we launched Nav, our digital platform.
Nav is the healthcare navigation platform that connects patients and physicians through an intuitive and empowering experience.
183,000consultations (90% emergency consultations and 10% specialty consultations)
R$32 millionin revenue from telemedicine and immediate navigation
49,000+test requests
R$29 million+in revenue from Nav patient and physician loyalty
324vaccine bookings
At Dasa, we connect knowledge and technology to challenge the status quo. We believe innovation is one of the main levers of both our integrated healthcare network and the transformation we want to spearhead in the healthcare industry. In 2021, we allocated R$1 billion+ to innovation. The highlights for 2021 include the open innovation concept, whose vision of all Dasa’s businesses became even more strategic and transversal.
Initiatives focused on expanding our healthtech community through partnerships with innovation hubs.
Creation of new policies and internal processes to enable business with startups and give more autonomy and speed to proofs of concept.
Construction of a new flow for mapping pain points and prospecting startups for connection.
We also invest in medical innovation, scientific research, and clinical studies, as well as enter into strategic partnerships to boost integrated lifelong care. On the clinical analysis and medical innovation front, we have the capacity to process 300 million tests per year.
In 2021, our clinical staff and healthcare professionals published 256 articles in scientific journals and presented 136 scientific papers in congresses.
At Dasa, we manage our people by caring for caregivers, valuing a diverse and inclusive environment, developing our team, and strengthening our culture.
For the second consecutive year, Dasa was included in the list of the best companies to work for in Brazil and received the GPTW seal. In 2021, we were also included in IGPTW B3, an index that reflects a theoretical portfolio of stocks that includes certified companies and the best companies to work for, according to the national GPTW ranking.
DiversiDasa, our diversity and inclusion program, works on five priority fronts: inclusion of people with disabilities, racial equality, gender equity, LGBTQIA+ inclusion, and generational diversity.
In 2021, we also reinforced our purpose and manifest, endorsed by the creation of a Diversity & Inclusion Policy, listing four priority goals for addressing affirmative actions through our diversity fronts.
To care for our employees as they work, we have an occupational health and safety management system that is in line with best practices and legal requirements, comprising policies, programs, and procedures, focusing on risk and accident prevention and health promotion, led by the Occupational Health and Medicine (SESMT) department.
Beyond our health and safety management system and as a way to care for caregivers, our Dasa Cuida (Dasa Cares) program implements initiatives focused on the balance, well-being, and support of our employees and their families.
Our integrated healthcare network has 250,000+ physicians and prescribers. Focusing on improving the experience of healthcare professionals, who represent one of the main links of our chain, in 2021, we launched our Nav Pro platform, which enables professionals to access all patient test results and receive notifications and alerts on possible conditions and critical tests, among other features.
reduction in adverse events among hospitalized patients with the News Protocol
physicians on the platform (3.6x more professionals on the platform compared to 2020)
customer satisfaction score²
patients had consultations
cancer patients safely navigated
day reduction in the time patients have to wait to have access to cancer treatment
increase in the number of cases discussed with the tumor board – in which our oncologists can store and discuss cancer cases in a structured way, with quality and safety
Our supply chain is extensive and diverse based on our peculiarities. In 2021, there were 6,000+ suppliers, 95% of whom were hired locally in Brazil.
For 2022, we plan to design a criticality matrix based on ESG criteria, which should guide the management of these stakeholders.
Our purpose to be the health people want and the world needs goes much beyond caring for patients and users; it extends to society as a whole. We allocated R$18 million+ to social initiatives in 2021. In the coming years, reflecting an in-depth diagnosis of the Company’s fronts, we will focus on our cause: a careful look at Women’s Health.
